CONTROVERSIES IN ANTIMICROBIAL THERAPY - FORMULARY DECISIONS ON 3RD-GENERATION CEPHALOSPORINS

被引:13
作者
BARRIERE, SL [1 ]
机构
[1] UNIV MICHIGAN,COLL PHARM,ANN ARBOR,MI 48109
来源
AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1986年 / 43卷 / 03期
关键词
D O I
10.1093/ajhp/43.3.625
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:625 / 629
页数:5
相关论文
共 16 条
[1]  
BARRIERE SL, 1984, CLIN PHARMACY, V3, P351
[2]   COST-CONTAINMENT OF ANTIMICROBIAL THERAPY [J].
BARRIERE, SL .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (04) :278-281
[3]   ASSESSMENT OF SERUM BACTERICIDAL ACTIVITY AFTER ADMINISTRATION OF CEFOPERAZONE, CEFOTAXIME, CEFTIZOXIME, AND MOXALACTAM TO HEALTHY-SUBJECTS [J].
BARRIERE, SL ;
OZASA, DC ;
MORDENTI, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 28 (01) :55-57
[4]   PROPHYLACTIC PARENTERAL CEPHALOSPORINS IN SURGERY - ARE THE NEWER AGENTS BETTER [J].
DIPIRO, JT ;
BOWDEN, TA ;
HOOKS, VH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1984, 252 (23) :3277-3279
[5]  
ENRIGHT SM, 1983, HOSP FORMUL, V18, P989
[7]   STUDY OF ANTI-MICROBIAL MISUSE IN A UNIVERSITY HOSPITAL [J].
MAKI, DG ;
SCHUNA, AA .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1978, 275 (03) :271-282
[8]   BACTERIAL-MENINGITIS IN INFANTS AND CHILDREN [J].
MARKS, MI .
INFECTION, 1984, 12 :S52-S57
[9]  
NEU HC, 1982, REV INFECT DIS, V4, pS374
[10]  
QUINTILIANI R, 1983, CLIN PHARMACY, V2, P360